recombin
fragment
protein
sever
acut
respiratori
syndrom
sar
coronaviru
saracov
gener
use
western
blot
wb
assay
compar
commerci
sar
elisa
method
confirm
sar
case
n
recombin
fragment
base
wb
posit
compar
commerci
elisa
use
heat
kill
sarscov
wb
use
four
recombin
fragment
confirm
sar
case
gener
lower
rate
detect
evalu
sera
healthi
control
n
result
two
weakli
posit
elisa
result
remaind
neg
protein
wb
demonstr
three
posit
result
control
histori
sar
contact
posit
result
noncontact
control
discrep
elisa
wb
aros
evalu
sera
individu
n
sarslik
symptom
posit
posit
data
suggest
wb
assay
may
particularli
use
elisaneg
sar
case
elisaposit
nonsar
case
sever
acut
respiratori
syndrom
sar
detect
china
spring
total
nine
case
includ
three
suspect
case
report
femal
patient
die
sar
caus
new
strain
human
coronaviru
cov
isol
sar
patient
unlik
human
cov
caus
mild
respiratori
infect
compris
approxim
common
cold
sarscov
caus
sever
respiratori
infect
progress
acut
lung
injuri
acut
respiratori
distress
syndrom
ard
mortal
around
earli
stage
sar
atyp
sar
patient
usual
demonstr
symptom
similar
common
cold
influenza
situat
detect
antibodi
sarscov
use
confirm
diagnosi
sar
also
import
analyz
immunogen
sarscov
capac
elicit
protect
immun
better
character
immun
respons
earli
diagnosi
understand
immunopathogenesi
sar
spike
protein
sarscov
heterodim
characterist
coronavirus
consist
two
noncoval
bound
protein
subunit
deriv
n
c
termin
halv
protein
coronaviru
infect
subunit
bind
specif
receptor
host
cell
follow
subunit
mediat
fusion
viru
host
cell
membran
lead
entri
viru
cell
previou
studi
coronaviru
infect
protein
potent
immunogen
induc
neutral
antibodi
infect
neutral
antibodi
typic
direct
certain
fragment
block
receptor
recognit
membran
fusion
coronaviru
recent
report
show
viral
receptor
bind
site
link
fragment
c
termin
suggest
antibodi
may
associ
gener
protect
immun
respons
order
understand
immunogenec
fragment
protein
sarscov
evalu
potenti
use
target
antigen
diagnost
elisa
assay
prepar
recombin
subunit
fragment
fig
evalu
serum
sarsrecov
patient
possibl
antibodi
antigen
order
compar
util
elisa
wb
assay
two
recombin
fragment
protein
use
sera
obtain
sar
patient
sampl
first
hospit
peke
univers
sera
collect
marker
molecul
weight
recombin
protein
kda
respect
number
patient
show
figur
wb
sera
health
donor
sar
contact
histori
sera
patient
recov
sar
date
sampl
collect
c
elisa
patient
gave
written
consent
blood
collect
hospit
ethic
review
committe
approv
studi
test
antibodi
gst
thioredoxin
trx
neg
serum
sampl
use
studi
sampl
store
evalu
four
fragment
sarscov
protein
trx
fusion
recombin
protein
subunit
recombin
protein
subunit
tail
gst
fusion
recombin
protein
amino
acid
residu
n
termin
gst
fusion
recombin
protein
amino
acid
residu
termin
express
escherichia
coli
describ
previous
briefli
express
fragment
protein
amplifi
templat
plasmid
contain
correspond
fulllength
cdna
sarscov
gene
gift
dr
yong
xie
hong
kong
univers
scienc
technolog
specif
primer
tabl
amplifi
product
digest
restrict
endonucleas
bamhi
kpni
fragment
cdna
insert
express
plasmid
respect
wherea
fragment
cdna
insert
verif
correct
sequenc
plasmid
transform
e
coli
respect
e
coli
cultur
medium
induc
iptg
h
e
coli
harvest
lyse
ultrason
inclus
bodi
ib
collect
thoroughli
wash
recombin
fusion
protein
protein
contain
tag
purifi
ninta
resin
qiagen
qiaexpress
protein
fuse
gst
protein
n
terminu
purifi
gstglutathion
sepharos
affin
system
screen
protein
sarscov
sera
sar
patient
healthi
donor
perform
western
blot
wb
briefli
everi
purifi
sar
recombin
protein
separ
sdspolyacrylamid
gel
electrophoresi
transfer
onto
nitrocellulos
membran
block
milk
membran
sequenti
incub
sera
dilut
goat
antihuman
igg
h
l
alkalin
phosphatas
conjug
promega
substrat
nbtbcip
promega
antibodyposit
sera
test
twice
verifi
immunoreact
mocktransfect
e
coli
lysat
made
vector
use
wb
analysi
neg
control
igg
antibodi
sera
sar
patient
detect
elisa
use
elisa
kit
huada
bioscienc
china
made
kill
sar
viru
serv
main
antigen
brief
alwel
dilut
serum
ad
incub
h
room
temperatur
rt
plate
wash
follow
addit
alwel
dilut
goat
antihuman
igg
h
l
alkalin
phosphatas
conjug
promega
h
rt
plate
wash
incub
alwel
substrat
solut
min
rt
immedi
read
microtit
plate
reader
antho
antho
austria
nm
sampl
optic
densiti
od
cutoff
co
valu
identifi
posit
co
valu
defin
co
valu
n
od
translat
igg
studi
n
od
b
co
set
tabl
sequenc
primer
amplif
fragment
sens
antisens
recombin
protein
fragment
recogn
sera
sarsrecov
donor
recombin
protein
estim
around
kda
kda
kda
kda
respect
fig
seroreact
analysi
perform
use
wb
elisa
sera
collect
donor
fulli
recov
sar
infect
sera
reactiv
kill
sar
viru
measur
elisa
kit
tabl
sera
sarsrecov
donor
sera
reactiv
recombin
protein
respect
detect
wb
detail
tabl
none
sera
control
healthi
donor
reactiv
use
kill
sar
viru
elisa
kit
except
weak
reaction
found
two
sampl
sera
collect
prior
outbreak
sar
od
respect
antibodi
also
detect
wb
sera
three
group
healthi
donor
posit
rate
shown
tabl
contrast
antibodi
fragment
wb
detect
sera
healthi
donor
sar
contact
histori
sera
healthi
donor
tabl
antisarscov
antibodi
antibodi
could
detect
sera
sarssuspect
patient
hong
kong
beij
elisa
wb
respect
tabl
posit
rate
antibodi
sera
less
sera
sar
patient
first
hospit
peke
univers
diagnos
sar
confirm
furthermor
select
elisaposit
serum
sampl
patient
compat
histori
diseas
prior
antibodi
recombin
protein
detect
three
sampl
tabl
order
evalu
diagnost
util
wb
assay
use
recombin
protein
fragment
sera
sarsrecov
donor
test
studi
patient
diagnos
sar
case
infect
time
interv
sampl
collect
time
avoid
possibl
error
caus
sampl
collect
differ
serum
sampl
antibodi
sarscov
detect
commerci
elisa
assay
also
posit
use
wb
recombin
protein
develop
antibodi
detect
use
either
test
method
healthi
control
sera
except
two
weakli
reactiv
sampl
furthermor
serum
one
patient
neg
commerci
elisa
wb
base
recombin
protein
suggest
commerci
elisa
kit
sar
combin
wb
assay
use
recombin
subunit
may
provid
improv
diagnost
capabl
antibodi
detect
wb
sera
sarsrecov
donor
control
group
thu
appear
antibodi
direct
less
use
make
diagnosi
sar
hand
antibodi
wb
detect
sera
sarsrecov
donor
donor
sar
contact
histori
commerci
elisaneg
serum
sampl
antibodi
wb
posit
possibl
due
destruct
alter
sarscov
surfac
protein
viral
prepar
process
elisa
kit
suggest
detect
antibodi
wb
may
use
make
diagnosi
sar
exposur
set
neg
sar
elisa
assay
howev
clinician
cautiou
interpret
weakli
posit
elisa
result
od
b
could
repres
antibodi
nonsarscov
crossreact
sarscov
antigen
prepar
elisa
kit
phenomenon
report
previous
shown
recombin
fragment
target
antibodi
detect
appear
provid
addit
use
diagnost
inform
howev
elisaposit
od
b
sera
identifi
patient
collect
sar
outbreak
symptom
includ
fever
sera
test
use
wb
assay
recombin
subunit
three
posit
addit
test
recombin
protein
requir
determin
wb
recombin
protein
prove
use
evalu
elisaposit
sera
patient
fulfil
criteria
diagnos
sar
order
evalu
util
wb
assay
recombin
subunit
aid
diagnosi
sar
sera
sarssuspect
patient
test
commerci
sar
elisa
assay
antibodi
sarscov
detect
serum
sampl
two
differ
group
suspect
sar
patient
use
combin
sar
elisa
assay
might
expect
posit
rate
serum
sampl
lower
found
sarsconfirm
case
obtain
first
hospit
peke
univers
may
due
nonsar
patient
present
within
two
group
andor
absenc
signific
antibodi
respons
earli
cours
sar
latter
circumst
correct
evalu
diagnost
effect
test
method
includ
elisa
wb
establish
use
sera
sarsconfirm
case
rather
sarssuspect
case
time
cours
antibodi
gener
sarscov
follow
onset
symptom
import
diagnost
issu
previous
report
vari
wide
day
month
follow
onset
fever
data
shown
sarscov
recombin
protein
express
e
coli
shown
recogn
antibodi
serum
coronavirusinfect
anim
furthermor
recombin
coronaviru
protein
express
e
coli
demonstr
antigen
receptor
bind
abil
data
suggest
recombin
may
potenti
use
product
sar
vaccin
base
part
observ
antibodi
protein
detect
rare
sampl
healthi
donor
contact
sar
patient
suggest
infect
andor
immun
respons
may
consist
gener
common
contact
could
explain
research
infect
even
longterm
contact
sarscov
prior
infect
conclus
find
suggest
diagnost
approach
use
sarscovspecif
compon
protein
may
increas
diagnost
accuraci
test
combin
convent
elisa
test
base
kill
viru
target
antigen
